Literature DB >> 21638149

Examination of the pharmacokinetics of active ingredients of ginger in humans.

Yanke Yu1, Suzanna Zick, Xiaoqin Li, Peng Zou, Benjamin Wright, Duxin Sun.   

Abstract

Ginger extracts have been studied in various clinical trials for different indications. However, the pharmacokinetics of the ginger active constituents in human biological matrices is not well investigated. This study aims to develop a LC-MS/MS method for simultaneous measurement of 6-, 8-, and 10-gingerols and 6-shogaol and study their pharmacokinetics in human plasma and colon tissues. A sensitive LC-MS/MS method was established and validated with a low limit of quantification of 2-5 ng/mL. The intra- and inter-day accuracy ranged from -7.3% to 10.4% and from -9.4% to 9.8%, respectively. The intra- and inter-day precision ranged from 0.9% to 10.9% and from 2.0% to 12.4%, respectively. The glucuronide and sulfate metabolites of 6-, 8-, and 10-gingerols and 6-shogaol in plasma and colon tissues were quantified after hydrolysis with β-glucuronidase and sulfatase. After oral dosing of 2.0 g ginger extracts in human, free 10-gingerol and 6-shogaol were detected in plasma with peak concentrations (9.5 ± 2.2 and 13.6 ± 6.9 ng/mL, respectively) at 1 h after oral administration, but no free 6-gingerol and 8-gingerol were detected in plasma from 0.25 to 24 h. The peak concentrations of glucuronide metabolites of 6-, 8-, and 10-gingerols and 6-shogaol were 0.47 ± 0.31, 0.17 ± 0.14, 0.37 ± 0.19, and 0.73 ± 0.54 μg/mL at 1 h, respectively. The peak concentrations of the sulfate metabolites of 6-, 8-, and 10-gingerols and 6-shogaol were 0.28 ± 0.15, 0.027 ± 0.018, 0.018 ± 0.006, and 0.047 ± 0.035 μg/mL at 1 h, respectively. Very low concentrations (2-3 ng/mL) of 10-gingerol glucuronide and sulfate were found in colon tissues. Pharmacokinetic analysis showed that half-lives of these four analytes and their metabolites were 1-3 h in human plasma. No accumulation was observed for 6-, 8-, and 10-gingerols and 6-shogaol and their metabolites in both plasma and colon tissues after multiple daily dosing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638149      PMCID: PMC3160151          DOI: 10.1208/s12248-011-9286-5

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  39 in total

1.  Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols.

Authors:  Shengmin Sang; Jungil Hong; Hou Wu; Jing Liu; Chung S Yang; Min-Hsiung Pan; Vladimir Badmaev; Chi-Tang Ho
Journal:  J Agric Food Chem       Date:  2009-11-25       Impact factor: 5.279

2.  Effects of a ginger extract on knee pain in patients with osteoarthritis.

Authors:  R D Altman; K C Marcussen
Journal:  Arthritis Rheum       Date:  2001-11

3.  [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo.

Authors:  Eok-Cheon Kim; Jeong-Ki Min; Tae-Yoon Kim; Shin-Jeong Lee; Hyun-Ok Yang; Sanghwa Han; Young-Myeong Kim; Young-Guen Kwon
Journal:  Biochem Biophys Res Commun       Date:  2005-09-23       Impact factor: 3.575

4.  Effectiveness of ginger for prevention of nausea and vomiting after gynecological laparoscopy.

Authors:  Sirirat Apariman; Sawinee Ratchanon; Budsaba Wiriyasirivej
Journal:  J Med Assoc Thai       Date:  2006-12

Review 5.  Molecular targets of [6]-gingerol: Its potential roles in cancer chemoprevention.

Authors:  Ademola A Oyagbemi; Adebowale B Saba; Odunayo I Azeez
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

6.  Ethnopharmacologic investigation of ginger (Zingiber officinale).

Authors:  N Mascolo; R Jain; S C Jain; F Capasso
Journal:  J Ethnopharmacol       Date:  1989-11       Impact factor: 4.360

7.  Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea.

Authors:  Giti Ozgoli; Marjan Goli; Fariborz Moattar
Journal:  J Altern Complement Med       Date:  2009-02       Impact factor: 2.579

8.  Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial.

Authors:  Porndee Chittumma; Kasem Kaewkiattikun; Bussaba Wiriyasiriwach
Journal:  J Med Assoc Thai       Date:  2007-01

9.  Antibacterial effect of Zingiber officinale and Garcinia kola on respiratory tract pathogens.

Authors:  J F T K Akoachere; R N Ndip; E B Chenwi; L M Ndip; T E Njock; D N Anong
Journal:  East Afr Med J       Date:  2002-11

10.  Anti-emetic principles of Magnolia obovata bark and Zingiber officinale rhizome.

Authors:  T Kawai; K Kinoshita; K Koyama; K Takahashi
Journal:  Planta Med       Date:  1994-02       Impact factor: 3.352

View more
  22 in total

1.  Oral intake of encapsulated dried ginger root powder hardly affects human thermoregulatory function, but appears to facilitate fat utilization.

Authors:  Mayumi Miyamoto; Kentaro Matsuzaki; Masanori Katakura; Toshiko Hara; Yoko Tanabe; Osamu Shido
Journal:  Int J Biometeorol       Date:  2015-01-26       Impact factor: 3.787

2.  Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer.

Authors:  Suzanna M Zick; D Kim Turgeon; Shaiju K Vareed; Mack T Ruffin; Amie J Litzinger; Benjamin D Wright; Sara Alrawi; Daniel P Normolle; Zora Djuric; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-11

3.  Characterization of thiol-conjugated metabolites of ginger components shogaols in mouse and human urine and modulation of the glutathione levels in cancer cells by [6]-shogaol.

Authors:  Huadong Chen; Dominique N Soroka; Yuhui Hu; Xiaoxin Chen; Shengmin Sang
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

4.  [10]-Gingerdiols as the major metabolites of [10]-gingerol in zebrafish embryos and in humans and their hematopoietic effects in zebrafish embryos.

Authors:  Huadong Chen; Dominique N Soroka; Jamil Haider; Karine F Ferri-Lagneau; TinChung Leung; Shengmin Sang
Journal:  J Agric Food Chem       Date:  2013-05-23       Impact factor: 5.279

5.  Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Xueji Zhang; Shu-Feng Zhou; Shengrong Zhu
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

6.  Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebo-controlled trial.

Authors:  Wolfgang Marx; Alexandra L McCarthy; Karin Ried; Luis Vitetta; Daniel McKavanagh; Damien Thomson; Avni Sali; Liz Isenring
Journal:  BMC Complement Altern Med       Date:  2014-04-09       Impact factor: 3.659

7.  [6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signaling.

Authors:  E K Radhakrishnan; Smitha V Bava; Sai Shyam Narayanan; Lekshmi R Nath; Arun Kumar T Thulasidasan; Eppurathu Vasudevan Soniya; Ruby John Anto
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

Review 8.  The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy.

Authors:  Iñaki Lete; José Allué
Journal:  Integr Med Insights       Date:  2016-03-31

9.  The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial.

Authors:  Wolfgang Marx; Alexandra L McCarthy; Karin Ried; Dan McKavanagh; Luis Vitetta; Avni Sali; Anna Lohning; Elisabeth Isenring
Journal:  Nutrients       Date:  2017-08-12       Impact factor: 5.717

10.  Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review.

Authors:  Yiming Li; Van H Tran; Colin C Duke; Basil D Roufogalis
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.